The healthcare distributor sets fiscal 2027 earnings guidance and announces a $5 billion share repurchase program.
McKesson Corp. projected adjusted earnings per share of $44.20 to $45.00 for fiscal 2027, aligning with long-term growth targets. The company also outlined plans to repurchase $5 billion in shares, reinforcing capital return strategies.
The guidance follows a period of steady earnings growth, with prior fiscal year adjusted EPS figures serving as a benchmark. Analysts had anticipated a conservative outlook, but the buyback plan signals confidence in cash flow stability.
Shares showed muted reaction in after-hours trading as investors digested the projections and capital allocation plans.